Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY62.24 CNY
Change Today 0.00 / 0.00%
Volume 5.6M
300109 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 04/28/15 All times are local (Market data is delayed by at least 15 minutes).

boai nky pharmaceuticals-a (300109) Snapshot

Open
CNY64.00
Previous Close
CNY62.24
Day High
CNY66.66
Day Low
CNY58.01
52 Week High
04/28/15 - CNY66.66
52 Week Low
04/28/14 - CNY10.82
Market Cap
7.2B
Average Volume 10 Days
6.2M
EPS TTM
CNY0.26
Shares Outstanding
115.2M
EX-Date
--
P/E TM
239.4x
Dividend
CNY1.00
Dividend Yield
0.10%
Current Stock Chart for BOAI NKY PHARMACEUTICALS-A (300109)

Related News

No related news articles were found.

boai nky pharmaceuticals-a (300109) Related Businessweek News

No Related Businessweek News Found

boai nky pharmaceuticals-a (300109) Details

Boai NKY Pharmaceuticals Ltd. develops, manufactures, and sells polyvinylpyrrolidone (PVP) series products primarily in China. It offers povidone, crospovidone, copovidone, 2-pyrrolidone, PVP/H2O2 complexes, PVM/MA copolymers, OraRez MS, cross linked polyvinlypyrrolidone, N-vinylpyrrolidone, N-vinylcaprolactam, 1-vinylimidazole, 1,3-diethenyl-2-imidazolidinone, ethyl vinyl ether, n-butyl vinyl ether, isobutyl vinyl ether, and tert-butyl vinyl ether to pharmaceutical, cosmetics, wine/beer/beverage, and other industries. The company is based in Jiaozuo, China.

boai nky pharmaceuticals-a (300109) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

boai nky pharmaceuticals-a (300109) Key Developments

Boai NKY Pharmaceuticals Ltd., 2014 Earnings Call, Apr 13, 2015

Boai NKY Pharmaceuticals Ltd., 2014 Earnings Call, Apr 13, 2015

Boai NKY Pharmaceuticals Ltd., Annual General Meeting, Apr 21, 2015

Boai NKY Pharmaceuticals Ltd., Annual General Meeting, Apr 21, 2015., at 13:30 China Standard Time. Agenda: To consider the 2014 work report of the board of directors; to consider the 2014 work report of the supervisory committee; to consider the 2014 annual report and its summary; to consider the 2014 financial resolution report; to consider the 2014 profit distribution plan; to consider the appointment of 2015 audit firm; and to consider the 2015 application for comprehensive credit business to banks.

Boai NKY Pharmaceuticals Ltd. Proposes Final Dividend for the Year 2014

Boai NKY Pharmaceuticals Ltd. has proposed final dividend of CNY 1.0 per 10 shares tax included for the year 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
300109:CH CNY62.24 CNY 0.00

300109 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 300109.
View Industry Companies
 

Industry Analysis

300109

Industry Average

Valuation 300109 Industry Range
Price/Earnings 100.0x
Price/Sales 27.7x
Price/Book 18.0x
Price/Cash Flow 238.6x
TEV/Sales 28.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BOAI NKY PHARMACEUTICALS-A, please visit www.china-pvp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.